CINCINNATI, July 12 /PRNewswire/ -- Ethicon Endo-Surgery, Inc. (EES), a Johnson & Johnson company, today announced ithas completed the divestiture of its Breast Care business to Devicor Medical Products, Inc., a portfolio company of GTCR. Financial terms of the transaction are not being disclosed.
Under the terms of the transaction, Devicor has acquired the
"Associates in the Breast Care business have made it what it is today: the global leader in vacuum assisted breast biopsy devices," said Karen Licitra, Company Group Chairman, and Worldwide Franchise Chairman, Ethicon Endo-Surgery. "The MAMMOTOME® brand is recognized worldwide, and we believe Devicor provides a promising fit to help the Breast Care business achieve its full potential."
About Ethicon Endo-Surgery, Inc.
Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, develops and markets advanced medical devices for minimally invasive and open surgical procedures, focusing on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. More information can be found at www.ethiconendo.com.
SOURCE Ethicon Endo-Surgery, Inc.
Subscribe to our Free Newsletters!
Adult immunization is needed for adults whose mandatory childhood vaccines were either missed out ...
Snake antivenom is a medicine used for the treatment of patients suffering from snake envenomation.
Breast Cancer Risk Assessment Calculator predicts the risk for breast cancer. Find list of breast ...View All